Anti-HCV agent, ribavirin, elevates the activity of clotting factor VII in patients with hemophilia: a possible mechanism of decreased events of bleeding in patients with hemophilia by ribavirin.
作者信息
Yamamoto K, Honda T, Matsushita T, Kojima T, Takamatsu J
出版信息
J Thromb Haemost. 2006 Feb;4(2):469-70. doi: 10.1111/j.1538-7836.2006.01761.x.
Abstract
摘要
Zotero 插件